Patent holdings for IPC class A61K 9/26

Total number of patents in this class: 364

10-year publication summary

18
15
8
12
14
4
9
6
1
1
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Takeda Pharmaceutical Company Limited
2708
8
Impax Laboratories, LLC
26
6
Société des Produits Nestlé S.A.
9220
5
Boehringer Ingelheim International GmbH
4698
5
McNEIL-PPC, Inc.
143
5
Purdue Pharma L.P.
498
5
Novartis AG
10883
4
Ethypharm
149
4
Hanall Biopharma Co., Ltd.
92
4
Jagotec AG
62
4
Teva Pharmaceutical Industries Ltd.
797
4
Teva Pharmaceuticals USA, Inc.
905
4
Wockhardt Research Centre
48
4
Cima Labs Inc.
42
3
Cosmo Technologies Limited
120
3
Hanall Pharmaceutical Company, Ltd.
18
3
IntelGenx Corp.
71
3
iX Biopharma Ltd.
54
3
Jiangsu Hengrui Medicine Co., Ltd.
706
3
Panacea Biotec Ltd.
81
3
Other owners 281